← Insider buys
EVLO

Evelo Biosciences, Inc. · Healthcare

Chief Medical Officer Duncan Mchale sold $33K of Evelo Biosciences, Inc.

Sold$32,657
$9.51Price
3,434Shares
−30%Stake

What EVLO did after the filing

Prices for EVLO after this filing aren't in yet.

Traded Tue, Aug 8. Filed Wed, Aug 9, 4:42 PM ET, after the close. Not investment advice.